Captopril CAS:62571-86-2 Umkhiqizi Supplier

I-Captopril nayo ikhonjiswe ukuthi ivimbela ukwakheka kwe-angiotensin II, i-peptide ye-bioactive evuselela i-angiogenesis futhi ikhulise ukuminyana kwe-microvessel.I-Captopril ikhombisa ukuvinjwa okungenakuncintisana komsebenzi we-tyrosinase monophenolase kanye nokuvinjwa kokuncintisana komsebenzi we-diphenolase.I-Captopril, kanye namanye ama-inhibitors e-ACE, ikhonjiswe ekwelapheni umfutho wegazi ophakeme, ukwehluleka kwenhliziyo, ukungasebenzi kwe-ventricular kwesokunxele ngemuva kwe-myocardial infarction, ne-diabetic nephropathy. Ukwelashwa kwe-nephropathy yesifo sikashukela ehambisana nesifo sikashukela esincike ku-insulin, i-captopril yehlisa izinga lokuqhubeka kokungasebenzi kahle kwezinso futhi ibambezele ukuwohloka kokusebenza kwezinso.